- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07235124
Motivasjon og nevrotransmittere hos roere
Psykobiologiske korrelater av prestasjonsmotivasjon og nevrotransmitterresponser på trening hos elite-roere
The goal of this observational study is to learn how motivation and body chemistry are linked during and after intense exercise in national-level rowers.
The main questions this study aims to answer are:
Do athletes with higher motivation show different changes in brain chemicals after exercise? How do hormone and neurotransmitter levels change during recovery after exercise?
Participants will:
Complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI) before the exercise test.
Perform a 6000-meter rowing test on an indoor rowing machine. Have blood samples taken three times: before exercise, immediately after exercise, and 1 hour after exercise.
Researchers will measure blood levels of testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG).
This study will help researchers understand how motivation and body chemistry work together to influence performance and recovery in highly trained athletes.
Studieoversikt
Detaljert beskrivelse
This study explores how motivation and body chemistry are connected during and after intense physical exercise in national-level rowers. Researchers want to understand how psychological factors, such as motivation to achieve goals, relate to changes in hormones and brain chemicals that occur with exercise and recovery.
Before the exercise test, participants will complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI). This questionnaire helps identify how strongly a person is driven to perform, overcome challenges, and reach success.
After the questionnaire, each participant will complete a 6000-meter rowing test on an indoor rowing machine. This test is designed to produce a high level of physical effort similar to competition conditions. Blood samples will be taken three times: before the test, immediately after the test, and one hour after recovery.
The blood samples will be used to measure levels of several hormones and neurotransmitters, including testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG). These substances are involved in stress response, motivation, reward, and recovery.
Researchers will compare the results from the motivation questionnaire with changes in hormone and neurotransmitter levels. The goal is to find out whether more motivated athletes show different chemical responses to exercise and recovery.
Findings from this study may improve understanding of how the mind and body interact during intense training. This knowledge could help athletes and coaches develop better ways to support motivation, performance, and recovery in high-level sports.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Polen, 61-871
- Poznań University of Physical Education
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
All participants were recruited and tested at the Central Sports Centre - Olympic Preparation Center (COS OPO) in Wałcz, Poland, during a national team training camp under standardized conditions.
Beskrivelse
Inclusion Criteria:
National-level male rowers Age between 18 and 25 years Minimum of 3 years of systematic rowing training Regular training load (at least 10 sessions per week during the competitive season) Good general health and medical clearance for maximal exercise testing
Exclusion Criteria:
Current illness, injury, or infection Use of medications or dietary supplements that could affect hormone or neurotransmitter levels Smoking or use of psychoactive substances Inadequate sleep or food intake before testing Refusal or inability to provide informed consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: RETROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Rowers
The study includes 24 national-level male rowers. All participants are healthy, highly trained athletes with at least 3 years of systematic rowing experience and regular intensive training. |
Participants perform a 6000-meter rowing test on an indoor ergometer at maximal effort to simulate race conditions and induce physiological fatigue. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in serum Cortisol levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Cortisol serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Testosterone levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Testosterone serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Dopamin levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Dopamin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Serotonin levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Serotonin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Beta-endorphin levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Beta-endorphin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum anandamide (AEA) levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of anandamide (AEA) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum 2-arachidonoylglycerol (2-AG)) levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of 2-arachidonoylglycerol (2-AG) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Testosterone-to-cortisol ratio (T:C)
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Ratio calculated from serum testosterone and cortisol concentrations (ng/mL), used as an indicator of anabolic-catabolic balance. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in TSerotonin-to-dopamine ratio (S:D)
Tidsramme: Before exercise, immediately after, and 1 hour after recovery
|
Ratio of serum serotonin to dopamine concentrations (ng/mL), reflecting neurochemical balance related to motivation and fatigue. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Achievement Motivation (LMI score)
Tidsramme: Before exercise (baseline)
|
Assessment of achievement motivation using the Inventory of Achievement Motivation (LMI). The questionnaire evaluates multiple dimensions of motivation, such as persistence, confidence in success, goal setting, and compensatory effort. Total and subscale scores are analyzed to identify individual motivational profiles. |
Before exercise (baseline)
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- LMI60002023
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Individual participant data (IPD) will not be shared. Data will be used only for internal analysis and dissemination in scientific publications in aggregate form, in accordance with ethical approval.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .